Press Room

May 9, 2014

Derek Raghavan, MD, PhD and John Sweetenham, MD, named HemOnc Today’s Chief Medical Editors

Derek Raghavan and John SweetenhamThorofare, NJ – SLACK Incorporated, publisher of HemOnc Today, announced that Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, and John Sweetenham, MD, FRCP, FACP, have been named Chief Medical Editors of HemOnc Today.

Raghavan, president of Levine Cancer Institute at Carolinas Healthcare System, will serve as Chief Medical Editor, Oncology. Sweetenham, senior director of clinical affairs and executive medical director at Huntsman Cancer Institute at the University of Utah, will serve as Chief Medical Editor, Hematology.

HemOnc Today is the leading independent cancer publication, delivering a unique mix of daily news paired with perspective from leaders in the field of hematology and oncology. Healio.com/HemOnc offers daily news, video and continuing medical education.

“We are pleased that Drs. Raghavan and Sweetenham have joined HemOnc Today as Chief Medical Editors. Their leadership, expertise and vision will ensure that HemOnc Today will remain the independent voice in hematology and oncology,” said Joan-Marie Stiglich, ELS, Chief Content Officer of SLACK Incorporated, the publisher of HemOnc Today.

Raghavan and Sweetenham succeed former Chief Medical Editor Harry S. Jacob, MD, FRCPath(Hon), and Associate Medical Editor Joseph R. Bertino, MD, who led HemOnc Today’s editorial board since the publication’s inception in March 2000.

Raghavan, an internationally renowned cancer researcher and medical oncologist, joined HemOnc Today’s Editorial Board in May 2011. During his 3 years at Levine Cancer Institute, he has spearheaded efforts to eliminate natural barriers to top-quality care, including access, cultural barriers, and distance to clinical and research sites.

“The opportunity to partner with John Sweetenham in providing medical editorial leadership to HemOnc Today is exciting, and will allow us to exercise our interest in the interplay of clinical practice and bench research, while also thinking carefully and strategically about cost and value in health care,” Raghavan said. “HemOnc Today is a very influential broadsheet, which isn’t tied to the agendas of professional societies, and it will give medical opinion leaders a chance to take a position that is evidence- and/or logic- based, and stand up for improved care and outcomes, and help point to the right path in defining value and strategic pathways in future cancer care.”

Sweetenham, who joined Huntsman Cancer Institute in April 2013, is an internationally recognized expert in the treatment of hematologic malignancies. His central research interest is lymphoma and the use of stem cell transplantation.

“As an oncologist/hematologist, I feel particularly energized to be working in a field in which new discoveries and new treatment approaches are emerging at an unprecedented rate,” Sweetenham said. “These advances, along with the increasing need for quality, accountability and evidence of effectiveness in the health care system, pose challenges for all of us to stay current in the scientific, clinical and care-delivery issues we face every day. I am excited to be joining Derek Raghavan to ensure that HemOnc Today is a current, evidence-driven and impartial source of information and opinion for oncologists and hematologists on all aspects of their practice.”

For more information, contact Lee Gaymon, Senior Director, Audience Development & Marketing, at lgaymon@slackinc.com, 856.848.1000 ext. 356.

 ###

About SLACK Incorporated
SLACK Incorporated, publisher of HemOnc Today, is a leading provider of information to targeted health care specialties. SLACK produces 42 publications in print and online; publishes more than 250 medical and allied health books; creates custom print and Internet-related projects; and produces convention daily newspapers and meeting supplements for a growing number of health care meetings. For more information, visit slackinc.com.